South African billionaire Ivan Saltzman quits Dis-Chem board, ending the founding family's 48-year presence
Ivan Saltzman resigned from the Dis-Chem board with immediate effect, barely three weeks after taking the non-executive seat he retired into.
Skip to content
Ivan Saltzman resigned from the Dis-Chem board with immediate effect, barely three weeks after taking the non-executive seat he retired into.
Saul Saltzman, son of Dis-Chem's billionaire founder Ivan Saltzman, has resigned from the board, loosening the founding family's grip on the retailer.
The Saltzman family has been ranked by the Bloomberg Billionaires Index for the first time with a $1.3 billion fortune built from a single Johannesburg pharmacy.
Ivan Saltzman built Dis-Chem from a single Johannesburg pharmacy in 1978 into a $1.7 billion healthcare chain and now faces his hardest task: handing it over.
Dis-Chem CEO Rui Morais is spending hundreds of millions on internal disruption to transform South Africa's second-largest pharmacy chain into an integrated healthcare provider.
South Africa's Human Rights Commission opened a hate speech investigation into Dis-Chem shareholder Mark Saltzman over posts on X containing the k-word and other racially inflammatory language.
Dis-Chem faces growing boycott calls after shareholder Mark Saltzman clashed with journalist Redi Tlhabi on social media over Palestine posts, drawing public anger at the pharmacy chain.
Mark and Dan Saltzman have sold R642 million ($37.9 million) in Dis-Chem shares months after inheriting a R6.8 billion stake from their parents.
Dis-Chem founder Ivan Saltzman will step back again in 2026, ending an executive era as the family reshapes its shareholding.
This not only cements the Saltzman family’s status among South Africa’s wealthiest but also underscores Dis-Chem’s strong market performance.
This recent gain follows an earlier increase of $18.79 million between Sept. 13 and Oct. 26.
The sell-off, a routine measure to trim his stakes in the leading group, follows Saltzman’s decision to step down as the CEO in June 2023.
The Saltzman family, who own 35.12 percent of Dis-Chem, played a key role in steering its growth into one of South Africa’s largest retail pharmacy chains.
The billionaire Saltzman family, who currently own a 35.1-percent stake in Dis-Chem, have solidified their status as one of the wealthiest families in South Africa.